MedTrace Logo

Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)

NCT01361139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2015-01-16

No results posted yet for this study

Summary

This is a study that seeks to characterize data obtained from patients with a variety of lung diseases using ultrasound signals obtained from the lung tissue. A standard ultrasound instrument in the doppler mode (not the imaging mode used in examination of pregnant women for instance) is placed on the chest wall and the unique software the investigators have developed analyzes the signal reflected back from within the lung. On the basis of pilot studies performed previously the investigators expect to receive different signals from different diseases. The investigators seek to further characterize these signals to enable accurate diagnosis of different lung diseases using our technology.

Conditions

  • Lung Disease, Chronic Obstructive
  • Lung Disease, Interstitial
  • Asthma
  • Sarcoidosis
  • Hypertension, Pulmonary

Sponsors & Collaborators

  • Clalit Health Services, Haifa and West Galilee

    collaborator OTHER

  • Echosense Ltd.

    lead INDUSTRY

Principal Investigators

  • Daniel Weiler, MD · Echosense Ltd.

  • Uzi Milman, MD · Clalit Health Services

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-10-31
Completion
2014-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361139 on ClinicalTrials.gov